Trial Profile
A multi-centre, randomised study of Zoledronic Acid versus Observation in Patients with Asymptomatic Myeloma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Bone metastases; Multiple myeloma
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.